Any stock, in context
BROOKS · Healthcare
Brooks Laboratories Limited
Observation · 15 Oct 2026
How these are readBrooks Laboratories closed at ₹70.42 on 15 Oct 2026, 9.2% above its 200-day average and 13.5% above its 50-day average: above both lines. It sits 46.2% below its highest close of the past year, in the second fifth of its one-year range. Over three months it rose 1.4%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Thinly traded: under ₹1 crore a day
- vs 200-day
- +9.2%
- the long line
- vs 50-day
- +13.5%
- the short line
- From 52w high
- −46.2%
- ₹36.30₹126.4
- 3 months
- +1.4%
- sector median −2.7% · 60 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹0.17 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +2.47%
- 1W
- –
- 1M
- +11.62%
- 3M
- +1.38%
- YTD
- –
- 1Y
- −42.83%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.